Current pharmacotherapy for Alzheimer's disease

Article Abstract:

Five major categories of drugs used in the Alzheimer's disease (AD) treatment such as cholinergic treatment, antiglutamatergic treatment, vitamins and antioxidants and others are studied. Results show that the introduction of these drugs for AD in the past decade has been welcome but it does not detract from the need to improve symptomatic therapy and to develop neuroprotective drugs.

Alzheimer Disease Controllers, Diagnosis, Alzheimer's disease, Anti-Alzheimer's disease agents

---

New treatments for neuropathic pain

Article Abstract:

The unmet medical need for more effective treatment for neuropathic pain is driving a large volume of research to discover new drugs. It is seen that most of the existing treatments are drugs introduced to treat other pain conditions or other medical conditions, which were observed to be effective for neuropathic pain.

Medicinal and Botanical Manufacturing, Medicinals and botanicals, Analgesics & Antipyretics NEC, Pain, Pain management, Analgesics

---

Advancements in the treatment of epilepsy

Article Abstract:

The article discusses various new therapeutic strategies and the advancements that are made in the management and treatment of epilepsy in humans. Several new anticonvulsants, dietary therapies and earlier surgical interventions are developed for the purpose.

Care and treatment, Technology application, Epilepsy, Magnetic resonance imaging

Similar abstracts:

• Abstracts: Understanding patient concordance in the management of leg ulcers
• Abstracts: Managing acute and chronic pain in sickle cell disease. Identifying the characteristics of children with pressure ulcers
• Abstracts: Picture perfect. Gaps in the training picture. How to fight for your future
• Abstracts: Advances in the treatment of prostate cancer. Molecular imaging in the development of cancer therapeutics. Advances in radiation oncology

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.